Advantage Alpha Capital Partners’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-52,876
Closed -$264K 164
2024
Q3
$264K Buy
+52,876
New +$264K 0.06% 162